Last updated on October 2014

A Phase 1/1b Study of MGCD516 in Patients With Advanced Solid Tumor Malignancies

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Non-Small Cell Lung Cancer | Renal Cell Carcinoma | Head and Neck Cancer | Solid Tumors
  • Age: 18 Years
  • Gender: Male or Female

Inclusion Criteria:

  • Metastatic or unresectable solid tumor malignancy
  • Standard treatment is not available
  • Adequate bone marrow and organ function

Exclusion Criteria:

  • History of a significant cardiovascular illness
  • Prolonged corrected QT (QTc) interval
  • Left ventricular ejection fraction < 50%
  • Symptomatic or uncontrolled brain metastases
  • Other active cancer

Recruitment Status: Open

Brief Description Eligibility Contact Research Team

Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.